Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)’s chief financial officer Sath Nirmalananthan will be presenting and taking part in a panel discussion at the Sachs 10th Annual Oncology Innovation Forum on 31 May, at the beginning of the ASCO meeting. Nirmalananthan will be participating in the ‘Advanced Immunotherapies Panel: Cell Therapies & Cancer Vaccines’, alongside other companies including AstraZeneca, BTIG and Lumanity. The panel will discuss the current and future role of cell therapies and cancer vaccines from 11:40am to 12:30pm CDT.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com